Get the Stockscreener App
11.34
0.00%
0.00
After Hours:
11.34
Alvotech Stock (ALVO) Latest News
FDA Accepts RDY & ALVO's Prolia & Xgeva Biosimilar BLA for Review - TradingView
Alvotech And Reddy’s Await US Denosumab Decision As Launch Date Closes In - Citeline News & Insights
Alvotech (NASDAQ:ALVO) Short Interest Update - MarketBeat
Alvotech and Dr. Reddy’s Announce FDA Acceptance of Biologic License Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva - BioSpace
Alvotech and Dr. Reddy’s gets FDA nod for Biologic License Application for AVT03 - MSN
Dr. Reddy’s, Alvotech announce FDA acceptance of BLA for AVT03 - TipRanks
Alvotech and Dr. Reddy’s biosimilar for Amgen's Prolia under FDA review - Seeking Alpha
Alvotech, Dr. Reddy's Announce FDA Acceptance Of Biologic License Application -March 18, 2025 at 09:50 am EDT - Marketscreener.com
Alvotech and Dr. Reddy's Announce FDA Acceptance of Biologic License Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva® - Lelezard
Dr. Reddy's, Alvotech Say FDA Accepts Biologic License Application for Bone Drug Biosimilar - Marketscreener.com
FDA Accepts Alvotech’s BLA for Biosimilar AVT03 - TipRanks
Alvotech and Dr. Reddy's Announce FDA acceptance of Biologic License Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva® - The Manila Times
FDA Green Lights Review of New Prolia Biosimilar: Major Win for Dr. Reddy's Cancer Treatment Pipeline - StockTitan
Major FDA Milestone: Alvotech's New Osteoporosis Drug Takes Crucial Step Forward - StockTitan
Alvotech (NASDAQ:ALVOW) Short Interest Update - Defense World
Alvotech at Barclays Healthcare Conference: Biosimilars Drive Growth By Investing.com - Investing.com South Africa
Alvotech at Barclays Healthcare Conference: Biosimilars Drive Growth - Investing.com India
Alvotech Meeting Investors and Participates in Fireside Chat At Barclays 27th Global Healthcare Conference in Miami, Florida - The Manila Times
Alvotech to Participate in Barclays 27th Annual Global Healthcare Conference in Miami, March 2025 - Nasdaq
Can Alvotech's CEO Reveal New Strategic Plans at Upcoming Barclays Healthcare Conference? - StockTitan
FDA Accepts Groundbreaking Golimumab Biosimilar Application From Alvotech-Teva Partnership - StockTitan
Alvotech is Now Oversold (ALVO) - Nasdaq
Pharmaceutical firms launch Stelara biosimilars - Drug Store News
FDA accepts Alvotech, Teva's BLA for proposed Eylea biosimilar - Drug Store News
Is Alvotech (ALVO) the Best Low Price Pharma Stock to Invest In Right Now? - Yahoo Canada Finance
Alvotech (NASDAQ:ALVO) Shares Up 5.5%Time to Buy? - MarketBeat
12 Best Low Price Pharma Stocks To Invest In Right Now - Insider Monkey
Alvotech to Report Full Year Financial Results for 2024 on - GlobeNewswire
Alvotech to Report Full Year Financial Results for 2024 on March 26, 2025, and Hosts Conference Call on March 27, 2025, at 8:00 am ET - The Manila Times
Alvotech to Release Full Year 2024 Financial Results on March 26, 2025, with Upcoming Investor Conference Call - Nasdaq
Alvotech Launches SELARSDI Biosimilar in U.S. Market - TipRanks
Alvotech heldur kynningarfund fyrir fjárfesta 27. mars 2025, eftir birtingu uppgjörs fyrir árið 2024 og fjórða ársfjórðung - GlobeNewswire
When Will Alvotech Reveal Its 2024 Performance? Key Dates for Investors - StockTitan
Teva and Alvotech launch ustekinumab biosimilar injection in US - Yahoo Finance
Teva Pharma and Alvotech launch biosimilar to J&J's Stelara in US - MSN
Teva/Alvotech follow Amgen in launching biosimilar for J&J’s Stelara - MSN
Alvotech (NASDAQ:ALVO) Shares Down 6.7%Here's What Happened - MarketBeat
Teva and Alvotech gets FDA review acceptance for its proposed biosimilar to Eylea - MSN
Teva, Alvotech announces U.S. availability of SELARSDI injection - TipRanks
Teva, Alvotech Launch SELARSDI, Stelara Biosimilar - Contract Pharma
Teva Pharma and Alvotech launch US biosimilar to J&J’s Stelara - PharmaLive
Teva Pharma and Alvotech launch US biosimilar to J&J's Stelara - MSN
Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S. - The Korea Bizwire
Teva Pharma and Alvotech launch US biosimilar to J&J's Stelara -February 21, 2025 at 06:27 am EST - Marketscreener.com
Alvotech og Teva tilkynna að sala er hafin í Bandaríkjunum - GlobeNewswire
Teva And Alvotech Announce Selarsdi(TM) Injection Now Available In The U.S. -February 21, 2025 at 06:07 am EST - Marketscreener.com
Teva Pharma and Alvotech launch Stelara biosimilar in US -February 21, 2025 at 06:09 am EST - Marketscreener.com
0.19%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):